To this end, as progenitor exhausted TCF1 + cells have stem cell-like properties and are likely responsible for the proliferative and functional immune responses that occur following immunotherapy [13], it is therefore not surprising that increased CD8 + TCF1 + is associated with improved DFS in breast cancer. This evidence concerns the gene CD8A and breast carcinoma.